MetLife Investment Management’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-25,773
Closed -$95.6K 2789
2024
Q4
$95.6K Buy
25,773
+20,474
+386% +$76K ﹤0.01% 2643
2024
Q3
$17K Sell
5,299
-17,874
-77% -$57.2K ﹤0.01% 2829
2024
Q2
$190K Buy
23,173
+5,157
+29% +$42.3K ﹤0.01% 2274
2024
Q1
$261K Hold
18,016
﹤0.01% 2048
2023
Q4
$166K Hold
18,016
﹤0.01% 2342
2023
Q3
$297K Hold
18,016
﹤0.01% 1962
2023
Q2
$114K Buy
+18,016
New +$114K ﹤0.01% 2599
2023
Q1
Sell
-17,480
Closed -$101K 2795
2022
Q4
$101K Hold
17,480
﹤0.01% 2589
2022
Q3
$164K Hold
17,480
﹤0.01% 2418
2022
Q2
$390K Hold
17,480
﹤0.01% 1837
2022
Q1
$961K Buy
17,480
+6,464
+59% +$355K 0.01% 1352
2021
Q4
$728K Hold
11,016
0.01% 1291
2021
Q3
$925K Hold
11,016
0.01% 1154
2021
Q2
$1.4M Hold
11,016
0.01% 1012
2021
Q1
$1.21M Buy
11,016
+563
+5% +$61.8K 0.01% 1066
2020
Q4
$1.49M Sell
10,453
-1,056
-9% -$151K 0.01% 953
2020
Q3
$812K Hold
11,509
0.01% 1134
2020
Q2
$805K Buy
11,509
+4,866
+73% +$341K 0.01% 1113
2020
Q1
$232K Hold
6,643
﹤0.01% 1610
2019
Q4
$418K Hold
6,643
﹤0.01% 1557
2019
Q3
$223K Hold
6,643
﹤0.01% 1882
2019
Q2
$173K Buy
+6,643
New +$173K ﹤0.01% 2116